Quarterly report [Sections 13 or 15(d)]

NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details)

v3.25.3
NET LOSS PER SHARE - Schedule of Diluted Shares Outstanding (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Backstop Notes | Senior Notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Percentage of common stock outstanding, issuable 9.90%   9.90%  
Common stock issuable due to grants of RSUs with service only (i.e., time-vesting) conditions        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 1,133,640 811,664 1,133,640 811,664
Common stock issuable on conversion of the Backstop Notes        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 1,920,007 1,920,007 1,920,007 1,920,007
Common stock issuable on exercise of private placement warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 54,556 54,556 54,556 54,556